Hantech Bio-Technology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	249.4	382.42	167.09	75.04	86.41
Trading Asset Securities	89.99	-	-	-	-
Cash & Short-Term Investments	339.38	382.42	167.09	75.04	86.41
Cash Growth	-11.25%	128.87%	122.67%	-13.16%	5.66%
Accounts Receivable	133.93	80.56	88.43	50.06	24.94
Other Receivables	1.59	0.21	0.21	0.01	0.01
Receivables	135.51	80.76	88.64	50.07	24.95
Inventory	108.32	70.34	80.47	29.32	22.04
Prepaid Expenses	5.09	1.11	3.72	4.24	1.78
Other Current Assets	3.23	-	-	-	-
Total Current Assets	591.53	534.63	339.91	158.68	135.17
Property, Plant & Equipment	558.71	566.87	551.32	285.23	227.04
Long-Term Investments	1.2	-	-	-	-
Other Intangible Assets	3.95	5.96	3.25	1.47	1.2
Long-Term Deferred Tax Assets	2.61	1.79	1.81	2.27	1.06
Other Long-Term Assets	8.33	9.75	34.65	25.95	11.17
Total Assets	1,166	1,119	930.94	473.59	375.65
Accounts Payable	115.69	46.33	99.17	33.7	13.67
Accrued Expenses	-	43.56	49.75	25.29	25.4
Short-Term Debt	-	-	-	1	4
Current Portion of Long-Term Debt	42.46	51.22	23.18	5.94	5.06
Current Portion of Leases	5.75	6.26	6.63	6.57	6.78
Current Income Taxes Payable	16.48	21.73	30.01	8.91	0.97
Current Unearned Revenue	-	13.25	10.38	13.51	10.24
Other Current Liabilities	66.09	9.86	5.22	1.82	1.21
Total Current Liabilities	246.47	192.21	224.34	96.74	67.35
Long-Term Debt	69.3	92.25	285.1	84.48	110.37
Long-Term Leases	13.86	9.1	15.35	20.84	18.53
Long-Term Unearned Revenue	-	4.57	4.77	2.95	1.49
Long-Term Deferred Tax Liabilities	0.01	0.05	-	0.01	-
Other Long-Term Liabilities	4.46	-	-	-	-
Total Liabilities	334.1	298.18	529.56	205.02	197.74
Common Stock	305.72	276.01	193.67	166.34	113.46
Additional Paid-In Capital	313.75	296.21	36.88	36.85	12.31
Retained Earnings	238.06	245.56	167.55	63.7	48.85
Treasury Stock	-28.36	-	-	-	-
Total Common Equity	829.16	817.78	398.09	266.89	174.62
Minority Interest	3.07	3.04	3.29	1.68	3.3
Shareholders' Equity	832.23	820.82	401.38	268.57	177.91
Total Liabilities & Equity	1,166	1,119	930.94	473.59	375.65
Total Debt	131.37	158.83	330.27	118.83	144.75
Net Cash (Debt)	208.01	223.6	-163.18	-43.79	-58.33
Net Cash Growth	-6.97%	-	-	-	-
Net Cash Per Share	6.79	7.64	-5.76	-1.68	-2.41
Filing Date Shares Outstanding	30.37	30.38	27.72	27.38	23.24
Total Common Shares Outstanding	30.37	30.38	27.72	27.38	23.24
Working Capital	345.06	342.42	115.57	61.94	67.83
Book Value Per Share	27.30	26.91	14.36	9.75	7.51
Tangible Book Value	825.22	811.82	394.84	265.42	173.42
Tangible Book Value Per Share	27.17	26.72	14.25	9.70	7.46
Land	-	214.44	214.44	87.04	87.04
Buildings	-	260.13	241.98	-	6.2
Machinery	-	149.35	113.95	87.08	83.76
Construction In Progress	-	-	9.78	125.77	61.92
Leasehold Improvements	-	7.43	7.4	7.36	1.02

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.